Thermosome Announces Participation in IMAGIO Consortium to Improve Cancer Treatment IMAGIO consortium of clinical partners coordinated by Philips receives EUR 24 million grant from the Innovative Health Initiative (IHI) and additional funding from industry partners to support the...

Seno Medical’s Imagio® Breast Imaging System Named Science and Medical Category Finalist in 2022 Edison Awards Program San Antonio, Texas, Feb. 08, 2022 (GLOBE NEWSWIRE) -- Seno Medical’s Imagio® Breast Imaging System has been named a finalist in the 2022 Edison Awards competition in the Science and Medical category...

Poster Presentation at RSNA Compares Seno Medical’s OA/US Breast Imaging with AI Decision Support to Ultrasound Alone; Finds Significantly Better Specificity to Support Clinical Decision Making Confidence. San Antonio, TX, Dec. 01, 2021 (GLOBE NEWSWIRE) -- A study presented at the Radiological Society of North America (RSNA)’s annual meeting showed Texas-based Seno Medical Instruments, Inc. (Seno)’s...

Seno Medical Launches CONFIDENCE Registry Study for Imagio® Breast Imaging System San Antonio, TX, Oct. 21, 2021 (GLOBE NEWSWIRE) -- Texas-based Seno Medical Instruments, Inc. (Seno) has launched its CONFIDENCE registry to evaluate the efficacy of imaging with...

FDA Approves Seno Medical’s Ground-Breaking Breast Cancer Diagnostic Technology San Antonio, TX, Jan. 19, 2021 (GLOBE NEWSWIRE) -- The Center for Devices and Radiological Health (CDRH) of the US Food & Drug Administration (FDA) has granted Texas-based Seno Medical...